Drug Shortage Report for MIRVALA 21
| Report ID | 54312 |
| Drug Identification Number | 02410249 |
| Brand name | MIRVALA 21 |
| Common or Proper name | DESOGESTREL+ETHINYL ESTRADIOL |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DESOGESTREL ETHINYL ESTRADIOL |
| Strength(s) | 0.1500MG 0.0300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 21 BLS |
| ATC code | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-07-02 |
| Estimated end date | 2018-08-13 |
| Actual end date | 2018-07-11 |
| Shortage status | Resolved |
| Updated date | 2018-07-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-07-12 | French | Compare |
| v3 | 2018-07-12 | English | Compare |
| v2 | 2018-07-04 | French | Compare |
| v1 | 2018-07-04 | English | Compare |
Showing 1 to 4 of 4